This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Pan-American Life Insurance Group Completes Acquisition Of Majority Of MetLife® Assets In The Caribbean, Panama And Costa Rica

Stocks in this article: MET

NEW ORLEANS, Aug. 1, 2012 /PRNewswire/ -- Pan-American Life Insurance Group (PALIG), a leading provider of insurance and financial services throughout the Americas, today announced it received regulatory approval and has completed its acquisition of assets and businesses of MetLife (NYSE: MET) in the Cayman Islands, Costa Rica, Panama, St. Lucia and Trinidad and Tobago. In an important next step, PALIG expects to receive regulatory approval and close on the remaining Caribbean countries over the next few months.

Upon closing in all jurisdictions, the PALIG acquisition will represent approximately $675 million in assets, encompassing 15 countries in Central America and the Caribbean. In total, the acquisition will represent more than $170 million in revenues (as of 2010).

"This purchase solidifies Pan-American Life Insurance Group's strategy to become one of the leading life and health insurance providers in the Americas," said Jose S. Suquet, Chairman of the Board, President and CEO of Pan-American Life Insurance Group. "For more than 100 years, Pan-American Life Insurance Group has provided trusted financial security to our policyholders. The completed acquisition builds on Pan-American Life Insurance Group's financial strength and expands our size and geographic footprint, while reinforcing our commitment to serving customers throughout the Americas." 

The regions acquired through this transaction greatly expand PALIG's international revenues further making these markets a priority as the company continues to expand its global footprint.

"This transaction aligns with our dedicated focus on our core competencies of life and health insurance. The addition of the MetLife – Alico/Algico business fits perfectly with Pan-American Life's strategic focus of becoming a leading life and health insurance carrier with international reach for insureds of both our corporate and personal lines," said Mr. Suquet. "Additionally, it ranks PALIG in the top three among life and/or health insurance carriers in nearly all markets in which it competes outside of the United States."

MetLife – Alico/Algico customers in the Caribbean and Central America will benefit from being insured by a provider that has a high-quality asset base, a strong balance sheet, financial strength ratings of A (Excellent) from AM Best and Fitch Ratings, an expanded footprint and 100 years of experience with a distinct focus of life and health insurance in the Americas, the Company said.

In connection with the acquisition, a PALIG insurer is now a MAXIS Global Benefits partner in the Caribbean, Panama and Costa Rica, as well as in Central America and Ecuador.  The MAXIS Global Benefits Network is a worldwide network created by MetLife and AXA to deliver optimal local insurance coverage to multinational companies through their own operations as well as independent carriers.

Terms of the transaction were not disclosed.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,778.15 +421.28 2.43%
S&P 500 2,061.23 +48.34 2.40%
NASDAQ 4,748.3960 +104.0840 2.24%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs